$Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture$

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture

Bibliographic Details
Main Authors:	Robinson, D, Ali, M, Delmestri, A, Prieto-Alhambra, D
Format:	Conference item
Published:	Wiley 2018

Similar Items

Adjustment for continuous confounders: an example of how to prevent residual confounding.
by: Groenwold, R, et al.
Published: (2013)

Negative control outcomes to control for unmeasured confounding in device safety research: a clinical example
by: Prieto Alhambra, D, et al.
Published: (2019)

A joint application of disease risk score and propensity score to control for confounding: A clinical example
by: Ali, M, et al.
Published: (2018)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
by: Oda, T, et al.
Published: (2021)

Increased fracture risk in women treated with aromatase inhibitors versus tamoxifen: Beneficial effect of bisphosphonates
by: Pineda-Moncusí, M, et al.
Published: (2019)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2019)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
by: Khalid, S, et al.
Published: (2021)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
by: Abrahamsen, B, et al.
Published: (2016)

GGPS1 mutation and atypical femoral fractures with bisphosphonates.
by: Roca-Ayats, N, et al.
Published: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)

Fracture risk following the initiation of antihypertensive therapy amongst frail elderly people: a self-controlled case series analysis
by: Jödicke, AM, et al.
Published: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
by: Reyes, C, et al.
Published: (2015)

Instrumental variables to test for unmeasured confounding: a precautionary note
by: Ali, MS, et al.
Published: (2017)

Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index
by: Nogués, X, et al.
Published: (2017)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
by: Prieto-Alhambra, D, et al.
Published: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Cardinality matching versus propensity score matching for addressing cluster-level residual confounding in implantable medical device and surgical epidemiology: a parametric and plasmode simulation study
by: Du, M, et al.
Published: (2024)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
by: Garriga, C, et al.
Published: (2017)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Fracture risk following bariatric surgery: a self-controlled case series and risk prediction algorithm
by: Robinson, DE, et al.
Published: (2019)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
by: Strauss, V, et al.
Published: (2018)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
by: Pazianas, M
Published: (2013)

Fracture risk estimation through the FRAX® scale
by: Prieto-Alhambra, D, et al.
Published: (2010)

Fracture risk in patients receiving concomitant bisphosphonate and proton pump inhibitors or bisphosphonates alone: The UK general practice research database
by: de Vries, F, et al.
Published: (2008)

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.
by: de Vries, F, et al.
Published: (2009)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2007)

Atopic eczema and fracture risk in adults: a population-based cohort study
by: Lowe, K, et al.
Published: (2019)

Confounding explanations....
by: Dunbar, R
Published: (2001)

The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
by: van Staa, T, et al.
Published: (2007)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
by: Javaid, M, et al.
Published: (2019)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
by: Ali, M, et al.
Published: (2018)

Self controlled case series in surgical epidemiology: the underlying assumptions demonstrated in an empirical example
by: Robinson, D, et al.
Published: (2019)

Self controlled case series in surgical epidemiology: checking the underlying assumptions in an empirical example
by: Robinson, D, et al.
Published: (2019)

Oral bisphosphonates and chronic kidney disease: progression and safety
by: Prieto-Alhambra, D, et al.
Published: (2018)